11630 SW 97 Street, Miami, Florida 33176, US
Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on novel treatments for rare diseases, announced today the Company has signed a definitive agreement with Mid-Atlantic BioTherapeutics, Inc. (MABT) to acquire worldwide rights […]
Read More>>(SAN DIEGO, Calif. – Aug. 19, 2020) — The number of Americans afflicted with Lyme disease was found to be 10 times greater than the 30,000 cases reported each year to the Centers for Disease Control and Prevention, according to […]
Read More>>